CDK9抑制剂-7

CDK9-IN-7

产品编号 :
Cas No. :
包装规格 纯度 目录价 会员专享价 库存 数量
5mg 98% 询价
- +
10mg 98% 询价
- +
晶智化学产品均仅供科研使用。在任何情况下,我们均不提供用于动物或人体用途的产品或服务。

基础信息

CAS No.

2369981-71-3

中文名称

CDK9抑制剂-7

英文名称

CDK9-IN-7

别名

CDK9-IN-7;7H-Pyrrolo[2,3-d]pyrimidine-6-carboxamide, 7-cyclopentyl-2-[[4-[(8-isothiocyanato-1-oxooctyl)amino]phenyl]amino]-N,N-dimethyl-;CDK-9-IN-7,CDK9IN7,CDK9 IN 7;CDK9-IN-7, 10 mM in DMSO;7-cyclopentyl-2-((4-(8-isothiocyanatooctanamido)phenyl)amino)-N,N-dimethyl-7H-pyrrolo[2,3-d]pyrimidine-6-carboxamide

标准英文名

7-cyclopentyl-2-((4-(8-isothiocyanatooctanamido)phenyl)amino)-N,N-dimethyl-7H-pyrrolo[2,3-d]pyrimidine-6-carboxamide

分子式

C29H37N7O2S

分子量

547.73

精确分子量

547.27

SMILES

O=C(C1=CC2=CN=C(N=C2N1C3CCCC3)NC4=CC=C(C=C4)NC(CCCCCCCN=C=S)=O)N(C)C

标准SMILES

CN(C)C(=O)C1=CC2=CN=C(NC3=CC=C(C=C3)NC(=O)CCCCCCCN=C=S)N=C2N1C1CCCC1

用途

CDK9-IN-7 is a potent, selective, and orally active CDK9/cyclin T inhibitor (IC50 = 11 nM) with anticancer activity and minimal toxicity; it induces apoptosis in non-small cell lung cancer (NSCLC) cells, arrests the cell cycle at the G2 phase, and suppresses NSCLC stem cell-like properties; it exhibits exceptional potency against NSCLC cell lines, particularly A549 and H1299 (IC50 < 0.5 µM), and shows effective inhibition in the drug-resistant NSCLC cell line H1975 (IC50 = 0.837 µM).

InChIKey

LLMKBTGLZJIAMY-UHFFFAOYSA-N

安全信息

SureRoute逆合成路线

1.  2369981-71-3 逆合成路线 1

—
—
—
—
ACENKL414
2369981-71-3
来源: SureRoute

2.  2369981-71-3 逆合成路线 2

—
—
—
—
ACENKL414
2369981-71-3
来源: SureRoute

3.  2369981-71-3 逆合成路线 3

—
—
—
—
ACENKL414
2369981-71-3
来源: SureRoute
评论 0
我是晶智Agent,
您的化学小助手